YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study

Launched by HERZ-ZENTRUMS BAD KROZINGEN · Apr 18, 2008

Keywords

ClinConnect Summary

Based on the fact that drug eluting stents have been proven to reduce the restenosis rate in the coronary arteries, we assume that YUKON-BTX-Sirolimus-eluting stent has a superior restenosis rate compared to treatment with uncoated stent in the below-the-knee arteries consecutively. The purpose of this study is to compare the restenosis rate of the treatment with balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX uncoated stent in patients with ischemic infrapopliteal arterial disease. Randomisation will be performed by extremity, that may lead to varying...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of peripheral arterial occlusive disease as defined by Rutherford 2-5
• • De-novo stenosis of \> 70% diameter stenosis in the tibioperoneal trunc, anterior and/or posterior tibial and/or peroneal artery
• • Target lesion length of ≤ 45 mm
• Exclusion Criteria:
• • Coagulation disorder
• • Known allergy to contrast medium
• • Contraindications to antiplatelet therapy or heparin